Navigation Links
Use of Implantable Cardioverter Defibrillators Canada Lags Behind U.S

The use of life-saving implantable cardioverter defibrillators in Canada is rising, but it is still significantly less than that in the United States. Dr. David Birnie and colleagues from the University of Ottawa Heart Institute report that, between 1995 and 2003, the use of implantable cardioverter defibrillators in adults who survived a cardiac arrest increased from 5.4% to 26.7% in Canada; in the US, the rate went up from 9.7% to 42.0%.

Implantable cardioverter defibrillators are small devices that require only a minor procedure to implant. If a life-threatening abnormal heart rhythm occurs, the device will activate and restore the rhythm to normal.

They are considered for use in people who have survived a cardiac arrest and in those who are felt to be at risk of a life-threatening rhythm disturbance.

In a related commentary, Dr. Christopher Simpson asks How is it that we continue to underuse this safe and effective therapy [in Canada]" He reviews many potential factors, including economics and bedside rationing, access problems, cultural values and reduced rates of death, and advocates for increased availability of this device.


'"/>




Page: 1

Related medicine news :

1. Implantable Contact Lens Found Safe and Effective
2. New Implantable Device That Can Keep The Heart Ticking
3. Making MRIs Safe for Patients With Implantable Heart Devices
4. Implantable devices to be powered by organosilicon compounds in the future
5. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
6. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
7. First Implantable artificial heart gets FDA’s approva
8. Defibrillators saving lives but price is an issue
9. Public Defibrillators Found To Improve Survival Rate
10. Defibrillators In Public Places Will Help Cardiac Patients
11. Reliability of Pacemakers and Defibrillators to be Improved
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... VEGAS, NEV. (PRWEB) , ... August 22, 2017 ... ... American Academy of Anti-Aging Medicine recently spoke at a popular international aesthetics conference ... therapy has had on restoring his patients’ health and his growing practice. , ...
(Date:8/22/2017)... ... August 22, 2017 , ... Five Star Glass is new to the Texas market, ... replacement of auto glass for most makes and models, in Grand Prairie, TX, located in ... , They have been a family owned business for the past 40 years with 32 ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Glimpses Of Light”: is a unique ... Of Light” is the creation of published author, J.M. Shepherd, a writer, teacher, traveler, ... to life’s perplexing mysteries. , Shepherd shares, “Love is one of the least understood ...
(Date:8/21/2017)... ... 22, 2017 , ... PracticeMatch, a company that provides online resources , ... and advanced practitioners like nurse practitioners and physician assistants , will ... of this year. The online career fairs will allow job seekers to connect with ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... today announced that it has become the Official Technology Partner of North Country ... AES (Advanced Event Systems) volleyball software, along with providing sport management software ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)...  West Pharmaceutical Services, Inc. (NYSE: WST ... 2017 and updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, ... Net sales at constant currency (organic) grew by 3.9%. ... compared to $0.60 in the prior-year quarter. Second-quarter 2017 ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: